Bristol-Myers Squibb Company
Global biopharmaceutical company focused on innovative medicines. Attractive valuation and high dividend yield.
The Bristol-Myers Squibb Company BMY dividend offers investors a current yield of 4.50% with 15 consecutive years of dividend payments, making it a compelling choice for income-focused portfolios.
Bristol-Myers Squibb Company BMY Dividend Metrics
10-Year Dividend History
Annual Dividend per Share ($)
Investment Highlights
Proven Dividend Track Record
The Bristol-Myers Squibb Company BMY dividend has been paid for 15 consecutive years, demonstrating consistent commitment to shareholder returns.
Attractive Dividend Yield
With a current dividend yield of 4.50%, Bristol-Myers Squibb Company offers a solid income stream with above-average yield potential.
Dividend Sustainability
The payout ratio of 60% suggests moderate dividend coverage with balanced distribution of earnings.
Investment Disclaimer
This information is provided for educational purposes only and does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Bristol-Myers Squibb Company stock information, dividend metrics, and analysis are provided as-is without any warranty. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past dividend performance does not guarantee future results.